UK MHRA approves ViiV Healthcare's cabotegravir formulations for HIV-1
|
The 600mg long-acting injection is the first injectable
treatment for HIV prevention approved in the UK. May 6, 2024. |
Study highlights importance of early interventions to combat HIV
A study has compared the development of HIV reservoirs—locations in the body where the virus persists in a latent state—between patients who ... View article...